AbbVie stock slipped when a House committee looking at drug prices said it would issue a subpoena, but the Allergan owner is working on coronavirus treatments. Is AbbVie stock a buy now?

The post AbbVie Joins The Coronavirus Drug Hunt — Is AbbVie Stock A Buy? appeared first on Investor's Business Daily.